Matrix Metalloproteinases in Atherothrombosis

被引:192
作者
Back, Magnus [1 ,2 ]
Ketelhuth, Daniel F. J. [2 ]
Agewall, Stefan [3 ,4 ]
机构
[1] Karolinska Univ Hosp, Dept Cardiol, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Dept Med, Stockholm, Sweden
[3] Aker Univ Hosp, Dept Med, Oslo, Norway
[4] Univ Oslo, Oslo, Norway
关键词
Atherosclerosis; Collagenase; Gelatinase; Inflammation; Lipoxygenase; Myocardial infarction; CORONARY-ARTERY-DISEASE; SMOOTH-MUSCLE-CELLS; CAROTID ATHEROSCLEROTIC PLAQUES; MONOCYTE-DERIVED MACROPHAGES; HUMAN MONONUCLEAR PHAGOCYTES; NECROSIS-FACTOR-ALPHA; E-DEFICIENT MICE; ACUTE MYOCARDIAL-INFARCTION; MMP-9 MICROSATELLITE POLYMORPHISM; PROMOTES COLLAGEN ACCUMULATION;
D O I
10.1016/j.pcad.2009.12.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The metalloproteinases (MMPs, matrixins) are zinc-containing endopeptidases involved in the metabolism of extracellular matrix as well as in the cleavage of other proteins. The MMP family currently consists of 28 enzymes with somewhat different activities. The members are in part categorized into groups according to either structure or preferred substrates and referred to as collagenases, gelatinases, stromelysins, matrilysins, and membrane-bound MMPs. The proteinase activities exerted by 11 of the 28 MMPs have been implicated in some of the biologic processes associated with atherosclerosis and its ischemic clinical manifestations such as myocardial infarction and stroke. For example, several of the MMPs are locally expressed within human atherosclerotic lesions. However, association studies of subclinical atherosclerosis have generated contradictory results in the role of MMP activities. In addition, circulating MMP levels as well as genetic variations within the genes encoding the different enzymes have been associated with both an increased and decreased cardiovascular risk. Finally, experimental studies of hyperlipemic mice and vascular injury have suggested some of the MMPs function as modulators of atherogenesis, vascular remodeling, and plaque rupture. © 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:410 / 428
页数:19
相关论文
共 236 条
[1]   Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin) [J].
Agnihotri, R ;
Crawford, HC ;
Haro, H ;
Matrisian, LM ;
Havrda, MC ;
Liaw, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (30) :28261-28267
[2]   Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis [J].
Alvarez, B ;
Ruiz, C ;
Chacón, P ;
Alvarez-Sabin, J ;
Matas, M .
JOURNAL OF VASCULAR SURGERY, 2004, 40 (03) :469-475
[3]   Leukotriene Signaling in Atherosclerosis and Ischemia [J].
Back, Magnus .
CARDIOVASCULAR DRUGS AND THERAPY, 2009, 23 (01) :41-48
[4]   Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis [J].
Bar-Or, A ;
Nuttall, RK ;
Duddy, M ;
Alter, A ;
Kim, HJ ;
Ifergan, I ;
Pennington, CJ ;
Bourgoin, P ;
Edwards, DR ;
Yong, VW .
BRAIN, 2003, 126 :2738-2749
[5]  
BARAGI VM, 1994, J BIOL CHEM, V269, P12692
[6]   A prospective evaluation of left ventricular remodeling after inaugural anterior myocardial infarction as a function of gene polymorphisms in the renin-angiotensin-alclosterone, adrenergic, and metalloproteinase systems [J].
Bauters, Christophe ;
Lamblin, Nicolas ;
Ennezat, Pierre V. ;
Mycinski, Christophe ;
Tricot, Olivier ;
Nugue, Olivier ;
Segrestin, Benoit ;
Hannebicque, Gery ;
Agraou, Benaissa ;
Polge, Anne Sophie ;
de Groote, Pascal ;
Helbecque, Nicole ;
Amouyel, Philippe .
AMERICAN HEART JOURNAL, 2007, 153 (04) :641-648
[7]   Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice [J].
Bea, Florian ;
Kreuzer, Joerg ;
Preusch, Michael ;
Schaab, Sandra ;
Isermann, Berend ;
Rosenfeld, Michael E. ;
Katus, Hugo ;
Blessing, Erwin .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (12) :2787-2792
[8]   Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia [J].
Beaueux, JL ;
Giral, P ;
Bruckert, E ;
Bernard, M ;
Foglietti, MJ ;
Chapman, MJ .
ATHEROSCLEROSIS, 2003, 169 (01) :139-146
[9]   AUTOLYTIC ACTIVATION OF RECOMBINANT HUMAN 72-KILODALTON TYPE-IV COLLAGENASE [J].
BERGMANN, U ;
TUUTTILA, A ;
STETLERSTEVENSON, WG ;
TRYGGVASON, K .
BIOCHEMISTRY, 1995, 34 (09) :2819-2825
[10]  
Bernal F, 2005, BIOL RES, V38, P267, DOI 10.4067/S0716-97602005000200016